Cough,
OTC Healthcare > Cough, cold and allergy (hay fever) remedies

Cough, Cold And Allergy (Hay Fever) Remedies in Sweden

Sweden

Euromonitor International's Cough, Cold And Allergy (Hay Fever) Remedies in Sweden market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 38  |  Publication date: May 2009
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Antihistamines/allergy remedies (systemic); Child-specific cough; cold and allergy remedies; Combination products - cough; cold and allergy (hay fever) remedies; Cough remedies; Decongestants; Medicated confectionery; Pharyngeal preparations

Table of contents

OTC HEALTHCARE IN SWEDEN : MARKET INSIGHT

EXECUTIVE SUMMARY

Sales remain dynamic in 2008

Calming and sleeping products most dynamic in 2008

Multinationals dominate

Deregulation of OTC healthcare retail expected in 2009

Deregulation to support growth

KEY TRENDS AND DEVELOPMENTS

Deregulation of OTC retailing expected in 2009

Economic stagnation impacts sales in 2008

More competitive environment as brands are challenged by generics

Ageing population has an impact on demand

Multinationals continue to dominate

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 5 OTC Healthcare Company Shares by Value 2004-2008

Table 6 OTC Healthcare Brand Shares by Value 2005-2008

Table 7 Penetration of Private Label by Sector 2003-2008

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

APPENDIX

OTC Registration and Classification

Advertising

Standardised packaging requirements

OTC healthcare to see distribution deregulation in 2009

Vitamins & Dietary Supplements Registration and Classification

EU Legislation

Self-medication and Preventative Medicine

Generics

Switches

Summary 1 OTC Healthcare Switches 2007-2008

DEFINITIONS

Summary 2 Research Sources

LOCAL COMPANY PROFILES - SWEDEN

ABIGO MEDICAL AB - OTC HEALTHCARE - SWEDEN

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Abigo Medical AB: Key Facts

Summary 4 Abigo Medical AB: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 5 Abigo Medical AB: Competitive Position 2008

ANTULA HEALTHCARE AB - OTC HEALTHCARE - SWEDEN

STRATEGIC DIRECTION

KEY FACTS

Summary 6 Antula Healthcare AB: Key Facts

Summary 7 Antula Healthcare AB: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 8 Antula Healthcare AB: Competitive Position 2008

BIOPHAUSIA AB - OTC HEALTHCARE - SWEDEN

STRATEGIC DIRECTION

KEY FACTS

Summary 9 Biophausia AB: Key Facts

Summary 10 Biophausia AB: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 11 Biophausia AB: Competitive Position 2008

CLEAN CHEMICAL SWEDEN AB - OTC HEALTHCARE - SWEDEN

STRATEGIC DIRECTION

KEY FACTS

Summary 12 Clean Chemical Sweden AB: Key Facts

Summary 13 Clean Chemical Sweden AB: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 14 Clean Chemical Sweden AB: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 15 Clean Chemical Sweden AB: Competitive Position 2008

MEDA AB - OTC HEALTHCARE - SWEDEN

STRATEGIC DIRECTION

KEY FACTS

Summary 16 Meda AB: Key Facts

Summary 17 Meda AB: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 18 Meda AB: Competitive Position 2008

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SWEDEN

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008

Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008

Table 14 Sales of Decongestants by Type: Value 2003-2008

Table 15 Sales of Decongestants by Type: % Value Growth 2003-2008

Table 16 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008

Table 17 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008

Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008

Table 19 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013

Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2009